-
公开(公告)号：KR1020120027654A
公开(公告)日：2012-03-22
申请号：KR1020100089363
申请日：2010-09-13
Applicant: (주)아모레퍼시픽
CPC classification number: A61Q19/08 , A61K8/97 , A61K36/48 , A61K2236/19 , A61K2800/85
Abstract: PURPOSE: A cosmetic composition containing fermented soybean extract fraction is provided to ensure excellent cell regeneration and wound healing. CONSTITUTION: A cosmetic composition contains 0.0001-30 wt% of fermented soybean extract fraction as an active ingredient. The fraction is prepared by extracting fermented soybean extract with organic solvent, filtering, centrifuging using a membrane filter, and decompressing. The cosmetic composition is manufactured in the form of a skin softener, massage cream, essence, nutrition cream, pack, and external use skin ointment.
Abstract translation: 目的：提供含有发酵大豆提取物级分的化妆品组合物，以确保优异的细胞再生和伤口愈合。 构成：化妆品组合物含有0.0001-30重量％的发酵大豆提取物组分作为活性成分。 通过用有机溶剂提取发酵的大豆提取物，过滤，使用膜过滤器离心和减压来制备级分。 化妆品组合物以皮肤柔软剂，按摩霜，精华液，营养霜，包装和外用皮肤软膏的形式制造。
-
公开(公告)号：KR101116447B1
公开(公告)日：2012-03-07
申请号：KR1020090047430
申请日：2009-05-29
Applicant: (주)아모레퍼시픽
Abstract: 본발명은피부세포의역동성활성화를위한화장료조성물에관한것으로, 보다상세하게는파피아글로메라타뿌리즙(Pfaffia glomerata root juice), 아르기닌피씨에이(Arginine PCA), 고련피추출물및 효모추출물을유효성분으로함유하여피부재생력을유지시키고피부세포의역동성을활성화시켜줌으로써피부미용에효과적이며피부주름방지, 미백, 보습, 피부트러블개선, 각질개선또는슬리밍성분들과함께사용하면그 효과를배가시켜주는화장료조성물에관한것이다.
-
公开(公告)号：KR101114141B1
公开(公告)日：2012-02-20
申请号：KR1020090081334
申请日：2009-08-31
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 항산화용 화장료 조성물에 관한 것으로, 보다 상세하게는 데이지, 메리골드, 홍화, 제라늄 및 팬지 꽃 추출물을 함께 함유하여 항산화 효과가 높고 피부결 개선 및 탄력 증진 효과가 우수한 화장료 조성물에 관한 것이다.
데이지 * 메리골드 * 홍화 * 제라늄 * 팬지 * 꽃 추출물 * 항산화 * 피부톤 개선 * 피부탄력 증진 * 피부결 개선 * 화장료 조성물-
公开(公告)号：KR1020110085371A
公开(公告)日：2011-07-27
申请号：KR1020100005125
申请日：2010-01-20
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K8/34 , A61K8/345 , A61K2300/00 , A61K2800/70 , A61Q19/005
Abstract: PURPOSE: A cosmetic composition containing natural plant extract is provided to suppress scalp inflammation and to relieve skin irritation. CONSTITUTION: A cosmetic composition for improving scalp condition contains 50.080.0 weight% of natural plant complex ingredients containing Nymphaea tetragona var. angusta CASP. extract, ginger extract, and bamboo extract. The natural plant complex ingredients further contain butylene glycol and phenoxy ethanol.
Abstract translation: 目的：提供含有天然植物提取物的化妆品组合物，以抑制头皮炎症和缓解皮肤刺激。 构成：用于改善头皮状况的化妆品组合物含有含有Nymphaea tetragona变种的天然植物复合成分的50.080.0重量％。 angusta CASP。 提取物，姜提取物和竹提取物。 天然植物复合成分还含有丁二醇和苯氧乙醇。
-
Patent Agency Ranking
公开(公告)号：KR1020110023337A
公开(公告)日：2011-03-08
申请号：KR1020090081142
申请日：2009-08-31
Applicant: (주)아모레퍼시픽
IPC: A61K8/97 , A61Q19/08 , A61K36/258 , A61K36/288
CPC classification number: A61Q19/00 , A61K8/97 , A61K36/232 , A61K36/258 , A61K36/288 , A61K36/71 , A61K36/8945 , A61K2800/87 , A61K2300/00
Abstract: PURPOSE: A method for enhancing skin regeneration efficiency of medicinal materials through double-boiling with a pottery is provided to be used in cosmetic products, health foods, or medicinal field. CONSTITUTION: A method for enhance skin regeneration efficiency is performed by extracting medicinal materials through double boiling at 20-180°Cwith a pottery. The medicinal materials are Taraxaci Herba, angelicae tenuissimae Radix, discoreae Rhizoma or Cimicifugae Rhizoma. A method for enhancing skin regeneration of medicinal materials comprises: a step of double-boiling for 60-80 hours; a step of cooling at room temperature for 12-36 hours; a step of double-boiling for 12-36 hours; a step of filtering medicinal materials; and a step of concentrating.
Abstract translation: 目的：提供化妆品，保健食品，医药领域中用于通过双层煮陶瓷提高药材的皮肤再生效率的方法。 构成：通过用陶器在20-180℃双沸腾提取药材来提高皮肤再生效率的方法。 药用材料为蒲公英，当归，白芷，根瘤菌。 一种用于增强药用材料的皮肤再生的方法包括：双沸腾60-80小时的步骤; 在室温下冷却12-36小时的步骤; 双层沸腾12-36小时; 过滤药材的一个步骤; 并集中精力。
-
公开(公告)号：KR1020100128807A
公开(公告)日：2010-12-08
申请号：KR1020090047430
申请日：2009-05-29
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A cosmetic composition for dynamic activation of skin cells is provided to maintain skin regeneration and to ensure skin care by activating dynamicity of skin cells. CONSTITUTION: A cosmetic composition for dynamic activation of skin cells contains Pfaffia glomerata root juice, arginine PCA, Melia azedarach L. skin extract and yeast extract. The Pfaffia glomerata root juice is contained in 0.00001-1.0 weight%. The arginine PCT is contained in 0.00001-1.0 weight% based on total weight of the composition. The composition further contains ingredients for anti-wrinkling, whitening, moisturizing, or slimming.
Abstract translation: 目的：提供用于皮肤细胞动态激活的化妆品组合物，以维持皮肤再生，并通过激活皮肤细胞的动力来确保皮肤护理。 构成：用于皮肤细胞动态激活的化妆品组合物含有Pfaffia glomerata根汁，精氨酸PCA，Melia azedarach L.皮肤提取物和酵母提取物。 Pfaffia glomerata根汁含量为0.00001-1.0重量％。 基于组合物的总重量，精氨酸PCT含量为0.00001-1.0重量％。 该组合物还含有抗皱，美白，保湿或减肥的成分。
-
公开(公告)号：KR1020090092235A
公开(公告)日：2009-08-31
申请号：KR1020090015228
申请日：2009-02-24
Applicant: (주)아모레퍼시픽
Abstract: A composition containing a sprout extract of plant is provided to enhance viability and proliferation of skin stem cell and delay skin aging. A composition for suppressing skin aging comprises Sequoia sprout extract, sun flower sprout extract and kale sprout extract as active ingredients. The composition further comprises bilberry sprout extract, peach sprout extract, broccoli sprout extract as active ingredients. The composition is used in the form of lotion, massage cream, nutrition cream, pack gel or skin viscosity type make-up material.
Abstract translation: 提供含有植物发芽提取物的组合物以增强皮肤干细胞的活力和增殖并延缓皮肤老化。 用于抑制皮肤老化的组合物包括红杉芽提取物，太阳花芽提取物和羽衣甘蓝提取物作为活性成分。 该组合物还含有越橘发芽提取物，桃芽提取物，西兰花发芽提取物作为活性成分。 该组合物以洗剂，按摩霜，营养霜，包装凝胶或皮肤粘度型补充材料的形式使用。
-
108.发明公开Ｒｈｏ ＧＤＩ-α를 포함하는 멜라닌 생성 조절용 조성물및 Ｒｈｏ ＧＤＩ-α를 이용하여 멜라닌 생성 조절제를스크리닝하는 방법 失效用于控制含有RHO GDI-α的成血作用的组合物，以及使用RHO GDI-α筛选造血调节剂的方法;
公开(公告)号：KR1020090054505A
公开(公告)日：2009-06-01
申请号：KR1020070121200
申请日：2007-11-27
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/64 , A61Q19/02 , G01N33/5008 , G01N2500/04
Abstract: A composition for regulating melanogenesis, which contains RhoGDI-alpha is provided to efficiently promote or inhibit melanogenesis using siRNA gene which suppresses RhoGDI-alpha expression. A composition for regulating melanogenesis comprises a RhoGDI-alpha protein or gene coding the same or a complementary gene of RhoGDI-alpha gene. The composition for regulating melanogenesis inhibits the expressions of MITF and tyrosinase. The composition for regulating melanogenesis promotes the expression of MITF and tyrosinase. A screening method of the composition for regulating melanogenesis includes confirmation of regulation of RhoGDI-alpha expression, activation or function.
Abstract translation: 提供了含有RhoGDI-α的用于调节黑素生成的组合物，用于抑制RhoGDI-α表达的siRNA基因有效促进或抑制黑素生成。 用于调节黑素生成的组合物包含编码RhoGDI-α基因相同或互补基因的RhoGDI-α蛋白或基因。 用于调节黑素生成的组合物抑制MITF和酪氨酸酶的表达。 用于调节黑素生成的组合物促进MITF和酪氨酸酶的表达。 用于调节黑素生成的组合物的筛选方法包括确认RhoGDI-α表达的调节，活化或功能。
-
109.发明公开ＣＰＴ-１ 유전자의 발현을 특이적으로 전사 단계에서조절하는 화학물질의 스크리닝 방법 및 그 방법으로검색된 제니스테인을 유효 성분으로 포함하는 ＣＰＴ-１발현 촉진제 有权特异性控制CPT-1基因转录表达的化合物的筛选方法和包含通过相同方法筛选的基因的CPT-1表达增强子
公开(公告)号：KR1020040060749A
公开(公告)日：2004-07-06
申请号：KR1020030095226
申请日：2003-12-23
Applicant: (주)아모레퍼시픽
IPC: C12N15/85
CPC classification number: C12N15/85 , C12N5/0693 , C12N9/1025 , G01N33/5044
Abstract: PURPOSE: A screening method of compounds specifically controlling transcriptional expression of CPT-1 gene, and a CPT-1 expression enhancer comprising genistein which is screened by the same method are provided, thereby easily screening natural compounds reducing fat of human. CONSTITUTION: The screening method of compounds specifically controlling transcriptional expression of CPT-1 gene comprises the steps of: constructing a recombinant plasmid pCPT-1P-luc containing CPT-1 promoter and luciferase; producing a transformant Huh7 cell line(KCLRF-BP-00090) transformed with the recombinant plasmid pCPT-1P-luc; contacting a compound with the transformant Huh7 cell line(KCLRF-BP-00090); quantification of the signal produced by the contact; and comparing the signal amount measured with that of a control.
Abstract translation: 目的：提供特异性控制CPT-1基因转录表达的化合物的筛选方法，以及通过相同方法筛选含有染料木素的CPT-1表达增强子，从而容易地筛选天然化合物，减少人的脂肪。 构成：特异性控制CPT-1基因转录表达的化合物的筛选方法包括以下步骤：构建含有CPT-1启动子和荧光素酶的重组质粒pCPT-1P-luc; 产生用重组质粒pCPT-1P-luc转化的转化体Huh7细胞系（KCLRF-BP-00090）; 使化合物与转化体Huh7细胞系（KCLRF-BP-00090）接触; 量化由接触产生的信号; 并将测量的信号量与对照的信号量进行比较。
-
-
-
-
-
-
-
-
Search Results
109
records
(took 0.03 seconds)
